Meet the Company

24 0

Approved Raptor Logo with (R) -04042014

 

 

 

 

VITAL SIGNS

NAME: Raptor Pharmaceuticals

HEADQUARTERS: Novato, CA

STOCK PRICE AS OF 10/15/2014: $10.19

52 WEEK RANGE: $7.12-$17.72

MARKET CAPITALIZATION: $639 million

EMPLOYEES: ~125

APPROVED COMPOUNDS: Cysteamine bitartrate delayed-release capsules (PROCYSBI®), FDA- approved in 2013 for treatment of nephropathic cystinosis in adults and children age 6 and older.

Related Post

Largest HD Clinical Trial Halted

September 1, 2014 0
Coenzyme Q10 “very unlikely” to show significant benefit in HD in 2CARE study The largest randomized, controlled trial ever conducted…

Editor’s Letter

September 1, 2014 0
Welcome to the 8th edition of HD Insights, released at the 8th European Huntington Disease Network Plenary Meeting in Barcelona,…